Deal Announcements

AxioMx Lands $2 Million Venture Capital Equity

Friday, December 28, 2012 5:57:00 AM PDT | VentureDeal

Branford, Connecticut  --  Biotechnology company AxioMx has raised an additional $2 million in new venture capital funding.

AxioMx has developed "synthetic recombinant antibody libraries with greater than 10 billion unique clones."

Elm Street Ventures and Connecticut Innovations made the investment.

Funding proceeds were not disclosed by the company.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1